Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
RxSight (RXST) Q2 Loss Beats Estimates
Via The Motley Fool
Tickers RXST
Exposures Product Safety
Artivion (AORT) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Tickers AORT
Exposures Financial Product Safety
Ascendis (ASND) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Tickers ASND
Exposures Financial Product Safety
Eli Lilly Shares Tumble After Disappointing Weight-Loss Pill Data
Via MarketMinute
Tickers AMGN LLY VKTX
Exposures Product Safety
Retail Traders Cheer Jazz Pharma After FDA Clears Rare Drug For Brain Tumor
Via Stocktwits
Tickers JAZZ
Exposures Product Safety
Arrowhead (ARWR) Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Tickers ARWR
Exposures Financial Product Safety
Eli Lilly Shares Tumble as Oral Weight-Loss Hope Falls Short of Lofty Expectations
Via MarketMinute
Topics Economy
Tickers AMGN GPCR LLY NVO
Exposures Product Safety Supply Chain
Replimune (REPL) Q1 Loss Widens 61%
Via The Motley Fool
Topics Intellectual Property
Tickers REPL
Exposures Intellectual Property Product Safety
JTE Mobility’s JT10 Mobility Scooter Receives FDA Class II Medical Device Classification
Via AB Newswire
Exposures Product Safety
Nortech (NSYS) Q2 EPS Jumps 140%
Via The Motley Fool
Topics Economy
Tickers NSYS
Exposures Product Safety Supply Chain
Achieve (ACHV) Q2 Net Loss Hits $12.7M
Via The Motley Fool
Tickers ACHV
Exposures Product Safety
BioMedNewsBreaks — Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Receives EU Approval to Launch EMBRACE Phase 3 MDD Study
Via Investor Brand Network
Tickers CYBN
Exposures Product Safety
NUVB Sales Jump 1,043% on Drug Launch
Via The Motley Fool
Topics Intellectual Property
Tickers NUVB
Exposures Intellectual Property Product Safety
UroGen (URGN) Q2 Revenue Rises 11%
Via The Motley Fool
Topics Intellectual Property
Tickers URGN
Exposures Intellectual Property Product Safety
Maxwell Biosciences Announces Closing of $20M Financing Round
Via Newsfile
Exposures Product Safety
Replimune Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - REPL
Via NewMediaWire
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Replimune Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi &amp; Korsinsky for More Information - REPL
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers REPL
Exposures Financial Legal Product Safety
Investors in Capricor Therapeutics, Inc. Should Contact Levi & Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR
Via NewMediaWire
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
August 11, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against RCKT
Via NewMediaWire
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
Investors in Capricor Therapeutics, Inc. Should Contact Levi &amp; Korsinsky Before September 15, 2025 to Discuss Your Rights - CAPR
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers CAPR
Exposures Financial Legal Product Safety
August 11, 2025 Deadline: Contact Levi &amp; Korsinsky to Join Class Action Suit Against RCKT
Via TheNewswire.com
Topics Fraud Lawsuit
Tickers RCKT
Exposures Financial Legal Product Safety
OS Therapies Announces Statistically Significant Positive Interim 2-Year Overall Survival Data from Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
Via Newsfile
Tickers OSTX
Exposures Product Safety
OPKO Health (OPK) Q2 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Tickers OPK PFE
Exposures Financial Product Safety
EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4
Via Benzinga
Tickers INBS
Exposures Product Safety
OS Therapies Receives Positive Feedback from UK MHRA Scientific Advice Meeting and Submits Innovative Licensing and Access Pathway (ILAP) Request for OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
Via Newsfile
Tickers OSTX
Exposures Product Safety
Palantir Exec Recalls Xi Jinping Predecessor's 1987 Dictum As China's Stronghold On Rare Earths Could Trigger 'Disaster' For America
Via Benzinga
Topics Product Recall
Tickers AAPL MP PLTR
Exposures Legal Product Safety
Time Management Expert Elisha Meek Grows Her Coaching Brand “It's Time”
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
Sun Pharma Hits Support Zone: Should You Buy The Dip Or Stay Away? SEBI RA Weighs In
Via Stocktwits
Topics World Trade
Exposures Product Safety Tariff
Vaxcyte (PCVX) Q2 Loss Widens 11%
Via The Motley Fool
Topics Intellectual Property
Tickers PCVX
Exposures Intellectual Property Product Safety
Dr. Jolee Roberts Advocates for Linking Oral Health to Whole-Body Wellness
Via Get News
Topics Product Recall
Exposures Legal Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.